Aclaris Therapeutics to Participate in Two June Healthcare Conferences

Company Overview - Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases [3] - The company has a multi-stage portfolio of product candidates supported by a robust R&D engine [3] Upcoming Events - Aclaris will participate in two healthcare conferences in June 2025: the Jefferies Global Healthcare Conference on June 4 at 10:30 AM EDT and the Goldman Sachs Global Healthcare Conference on June 11 at 1:20 PM EDT [5] - A live and archived webcast of both events will be available on the Aclaris website for at least 30 days [2]